DeepMed Research

National Heart, Lung, and Blood Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Genetics and Pain Severity in Sickle Cell Disease

Completed

Conditions: Pain
Quantitative Sensory Testing (QST)
GCH1
Genotype
Genetic Variation

First Posted Date: 2011-09-27

Last Posted Date: 2020-12-10

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 67

Registration Number: NCT01441141

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Ultrasound and Other Images of Artery Blockages

Terminated

Conditions: Atherosclerosis

First Posted Date: 2011-08-18

Last Posted Date: 2019-12-03

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 12

Registration Number: NCT01419574

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Decitabine for High-Risk Sickle Cell Disease

Phase 2

Completed

Conditions: Neutropenia
Sickle Cell Disease

Interventions: Drug: Decitabine

First Posted Date: 2011-06-17

Last Posted Date: 2017-03-01

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 10

Registration Number: NCT01375608

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Eltrombopag for Moderate Aplastic Anemia

Phase 2

Active, not recruiting

Conditions: Unilineage Bone Marrow Failure Disorders
Moderate Aplastic Anemia

Interventions: Drug: Eltrombopag

First Posted Date: 2011-04-04

Last Posted Date: 2024-12-03

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 34

Registration Number: NCT01328587

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions

Completed

Conditions: Bicuspid Aortic Valve With Family History
Familial Thoracic Aortic Aneurysm and Dissections
Other Congenital Heart Disease
Marfan Syndrome
Bicuspid Aortic Valve With Coarctation
Shprintzen-Goldberg Syndrome
Turner Syndrome
Ehlers-Danlos Syndrome
Loeys-Dietz Syndrome
Bicuspid Aortic Valve Without Known Family History

First Posted Date: 2011-03-24

Last Posted Date: 2016-12-20

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 3706

Registration Number: NCT01322165

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

and more 4 locations

Topical Sodium Nitrite for Chronic Leg Ulcers in Adult Patients With Blood Disorders

Phase 1

Completed

Conditions: Sickle Cell Disease
Chronic Hemolytic Disorders
Sickle Cell Anemia

First Posted Date: 2011-03-16

Last Posted Date: 2018-10-22

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 28

Registration Number: NCT01316796

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Real-time MRI Right Heart Catheterization Using Passive Catheters

Phase 1

Completed

Conditions: Congenital Heart Disease
Pulmonary Hypertension
Caridovascular Disease

Interventions: Procedure: Cardiac Real-time MRI RHC (Right Heart Catheterization)

First Posted Date: 2011-02-01

Last Posted Date: 2019-04-05

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 150

Registration Number: NCT01287026

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans Syndrome

Phase 2

Completed

Conditions: Constrictive Bronchiolitis
Graft vs Host Disease
Bronchiolitis, Exudative
Bronchiolitis Obliterans
Bronchiolitis, Proliferative

Interventions: Drug: Cyclosporine Inhalation Solution

First Posted Date: 2011-02-01

Last Posted Date: 2020-09-24

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 25

Registration Number: NCT01287078

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Effects of Systemically Administered Hydrocortisone on the Immune System in Healthy Volunteers

Completed

Conditions: Healthy Subjects
Immunosuppression
Healthy

First Posted Date: 2011-01-24

Last Posted Date: 2018-09-04

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 22

Registration Number: NCT01281995

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans

Phase 2

Completed

Conditions: Bronchiolitis, Proliferative
Bronchiolitis, Exudative
Bronchiolitis Obliterans
Constructive Bronchiolitis
Graft Versus Host Disease
Graft-Versus-Host Disease

Interventions: Drug: Cyclosporine Inhalation Solution (CIS)

First Posted Date: 2011-01-10

Last Posted Date: 2020-09-18

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 7

Registration Number: NCT01273207

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy